The age of cell and gene therapy (CGT) has arrived, fundamentally changing everything we thought we knew about pharmaceutical manufacturing and supply chain planning. With patient-specific batches, stringent timelines, and zero tolerance for error, traditional planning tools – especially spreadsheets – simply can’t cope with CGT scheduling.
Yet, despite the complexities, many CGT innovators and contract development and manufacturing organizations (CDMOs) still rely heavily on spreadsheets for scheduling. It’s time to address why this practice is not just outdated but also risky, and how purpose-built, AI-driven solutions are essential for CGT success.
Spreadsheets were created for book-keeping and data tabulation and, while tools like Excel have introduced advanced functionality over the years, they were fundamentally never intended to handle the complexity of detailed planning – let alone CGT scheduling. At the end of the day, they’re static tools that lack the ability to dynamically model the realities of patient-specific therapies. In particular, spreadsheets simply cannot:
These limitations cause costly delays, batch failures, lost samples, and ultimately, jeopardize patient treatment timelines and outcomes. In CGT, each of these errors directly impacts patient health, making accurate and responsive scheduling an essential component of advanced therapy management.
Understanding the gravity of these issues, Binocs™ was specifically designed to handle the intricate realities of CGT scheduling. Unlike generic scheduling tools, Binocs incorporates advanced AI-driven algorithms that proactively address CGT’s distinctive challenges:
To further streamline operations, Binocs offers advanced integration capabilities, enabling seamless connections with other critical systems across your supply chain. This embedded integration ensures accurate prioritization of batches, coordinated scheduling across production and QC teams, and timely updates in response to changing conditions.
For example, Binocs can integrate effortlessly with enterprise planning systems (such as OMP’s Unison Planning™ and others) to provide real-time visibility into batch statuses, operational constraints, and resource availability. But we also realize that, alongside such full-suite tools, CGT teams will inevitably continue to use Excel to manage many secondary aspects of their planning. That’s why we’ve made it straightforward and simple to connect Binocs to your Excel spreadsheets (and MS Project plans – and almost any other file type).
These integrations ensure that decisions made upstream or downstream are instantly reflected within Binocs, significantly enhancing planning accuracy and operational agility. They also ensure that you can use Binocs to supplement and enhance your existing systems.
In CGT scheduling, efficiency translates directly to patient outcomes. By moving beyond spreadsheets to a specialized solution like Binocs, CGT teams dramatically reduce batch delays, failed samples, and operational uncertainty. This leads directly to shorter time-to-patient windows, more reliable treatment outcomes, and increased patient safety and satisfaction.
With Binocs, each patient batch is tracked, prioritized, and scheduled intelligently, minimizing the risk of errors and maximizing the potential for successful therapy delivery. It transforms planning from a purely operational function into a strategic advantage.
The complexity of CGT planning demands tools built explicitly for its unique challenges. Binocs isn’t just a planning improvement, it’s a necessity for any CGT innovator or CDMO aiming to lead in the new therapeutic age.
Let’s explore the possibilities together.
